The U.S. government will give pharmaceutical company Moderna $176 million for a High Path Avian Flu vaccine, according to Reuters.
It uses the same technology as the COVID-19 vaccine, and Moderna began development and testing it last year on adults.
“mRNA vaccine technology offers advantages in efficacy, speed of development and production, scalability, and reliability in addressing infectious disease outbreaks, as demonstrated during the COVID-19 pandemic,” said Moderna CEO Stephane Bancel.
So far, four agriculture workers have contracted the virus since 2022.
Related Stories
Seth Boffeli, AARP Fraud Watch Network Senior Advisor, brings us a preview of tonight’s “RURAL AMERICA LIVE with AARP,” which will focus on tips for fighting fraud.
A group of 32 Democratic senators is urging ag lawmakers to halt their opposition to Prop 12 in the next Farm Bill.
In honor of Rural Road Safety Week, we’re highlighting some commonly overlooked hazards on rural roads, where 40 percent of all fatal crashes in the United States occur.
The network includes labs across the country that track diseases like New World Screwworm, which could see a rise in cases with hurricane season approaching.
Sen. Roger Marshall (R-KS) hosted the talks. The senator and doctor joined us on Wednesday on RFD-TV’s Market Day Report to recap the critical discussions surrounding human health in America.
Ag Secretary Brooke Rollins made the announcement yesterday at the grand opening of a new food safety lab in Missouri, where researchers will do Listeria testing.
